Antiretroviral News and Research

RSS

Unorthodox vaccine could one day help to prevent or control HIV infection

Researchers at Baylor College of Medicine (BCM) in Houston have reason to believe their unorthodox vaccine could one day help to prevent or control HIV infection, according to a study published in today's edition of Public Library of Science Medicine.

6 Jan 2006

Nothing changes - AIDS drug goal defeated by bureaucracy

A recent report on the failure of the United Nations "3 by 5" AIDS initiative, says that because of bureaucracy, poor management and inadequate funding, a global drive to put 3 million poor people on life-saving AIDS drugs by the end of 2005, has been defeated.

28 Nov 2005

Zinc supplements shown to be good for children with HIV

According to new research zinc supplements are a safe and effective way to reduce illness in children with HIV.

28 Nov 2005

Zinc supplements safe for chidren with HIV

Zinc-deficient children living in communities where they do not receive adequate amounts of zinc from their diet should be given supplements, even if they are HIV-infected, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions.

26 Nov 2005

United Kingdom has among the highest reported rates of primary resistance to HIV drugs worldwide

Those infected with HIV in the UK have one of the highest rates of resistance to anti-HIV drugs of anywhere in the world, prompting fears of a second wave epidemic of resistant virus, a new study claims in the British Medical Journal (BMJ).

26 Nov 2005

People taking highly active antiretroviral therapy for HIV infection remain susceptible to tuberculosis

...though the risk is lower than for HIV-infected patients not on HAART, according to an article in the Dec. 15 issue of Clinical Infectious Diseases, now available online.

13 Nov 2005

HIV antiretroviral therapy does help those in third world

With preliminary results from a study in Botswana, Harvard School of Public Health researchers have found that people with HIV-1 subtype C in resource-poor settings, who receive antiretroviral (ARV) therapy, can achieve comparable results to those in the developed world.

7 Nov 2005

HIV-positive patients have shorter survival periods while awaiting liver transplants

A new study on HIV-positive patients eligible for liver transplants found that their survival while waiting for a transplant is significantly shorter than patients who are HIV-negative.

7 Nov 2005

Socioeconomic status determines life expectancy in HIV patients

HIV patients with a low socioeconomic status are likelier to die much more often than patients with higher levels of wealth and education, a new UCLA study has found.

3 Nov 2005

New strategies to help developing countries address neglected diseases

For the health challenges facing developing countries, the numbers alone are staggering. Every day, 40,000 people - enough to fill a sports stadium - die from preventable infectious diseases and malnutrition. Entire generations of human potential are perishing.

25 Oct 2005

Importance of the drug Fuzeon (enfuvirtide) in the management of HIV

New potent combinations make suppression of virus to undetectable levels more achievable for treatment-experienced HIV patients.

20 Oct 2005

Survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapy

Many of the more than 5 million HIV-infected people living in India have been unable to obtain treatment due to the high cost. With the introduction of generic ART into India in 2000, the price of HIV drugs fell from $778 per month to $100 per month, and eventually declined even further to just $33 per month in 2003.

19 Oct 2005

No shred of evidence that HIV-positive men who lose fat in their legs reciprocally gain fat in their bellies

There is no syndrome that causes increased belly fat and decreased facial and limb fat among HIV-positive men who take antiretroviral drugs, according to a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.

13 Oct 2005

New way to measure the impact of AIDS on the living brain

A new University of California - Los Angeles/University of Pittsburgh imaging study for the first time shows the selective pattern of destruction inflicted by AIDS on brain regions that control motor, language and sensory functions. High-resolution 3-D color scans created from magnetic resonance images (MRI) vividly illustrate the damage.

10 Oct 2005

Clinical trials of daily oral antiretroviral dosing as pre-exposure prophylaxis

Writing in the journal Science, an international team of researchers, clinicians and others explains that a promising, relatively new approach is for people not infected but at high risk to take drugs that might prevent them from contracting HIV. But debate over the particulars of the strategy has slowed progress.

3 Oct 2005

No specific antiretroviral drug-related "Crix belly" syndrome

Contrary to the concerns of many HIV-infected patients, there appears to be no specific antiretroviral drug-related "syndrome" of changes in body fat distribution in men wherein leg and arm fat decrease as belly fat increases, reports a study in the October issue of Journal of Acquired Immune Deficiency Syndromes (JAIDS).

28 Sep 2005

Emergence of "POZ Parties"

The emergence of "POZ Parties" - parties exclusively for HIV positive men to meet other HIV positive men for sex - signals the potential to spread HIV "superinfection,"suggests research in Sexually Transmitted Infections.

28 Sep 2005

Drug-releasing intravaginal ring could help prevent women from contracting HIV infection

The silicone vaginal ring steadily releases aciclovir: a treatment for genital herpes. It is known that women with genital herpes are at increased risk of HIV infection because the genital blisters caused by the infection increase the transmissibility of sexually acquired HIV.

28 Sep 2005

Testing for drug resistance in HIV-infected patients at the time of diagnosis may increase patients' life expectancy

Resistance to antiretroviral therapy, even in patients who have never received treatment, is a growing concern. However, genotype resistance testing, which involves looking for the presence of resistance genes, is not a standard procedure at the time a patient is diagnosed with HIV, probably due to lack of data on its benefits and its relatively high cost compared with other routine blood tests.

26 Sep 2005

New study into the health-related quality of life for human immunodeficiency virus (HIV) patients

Pharmacists in Wales have conducted a new study into the health-related quality of life for human immunodeficiency virus (HIV) patients. The surprising results were revealed at the British Pharmaceutical Conference in Manchester.

26 Sep 2005

Antiretroviral News and Research

Unorthodox vaccine could one day help to prevent or control HIV infection

Nothing changes - AIDS drug goal defeated by bureaucracy

Zinc supplements shown to be good for children with HIV

Zinc supplements safe for chidren with HIV

United Kingdom has among the highest reported rates of primary resistance to HIV drugs worldwide

People taking highly active antiretroviral therapy for HIV infection remain susceptible to tuberculosis

HIV antiretroviral therapy does help those in third world

HIV-positive patients have shorter survival periods while awaiting liver transplants

Socioeconomic status determines life expectancy in HIV patients

New strategies to help developing countries address neglected diseases

Importance of the drug Fuzeon (enfuvirtide) in the management of HIV

Survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapy

No shred of evidence that HIV-positive men who lose fat in their legs reciprocally gain fat in their bellies

New way to measure the impact of AIDS on the living brain

Clinical trials of daily oral antiretroviral dosing as pre-exposure prophylaxis

No specific antiretroviral drug-related "Crix belly" syndrome

Emergence of "POZ Parties"

Drug-releasing intravaginal ring could help prevent women from contracting HIV infection

Testing for drug resistance in HIV-infected patients at the time of diagnosis may increase patients' life expectancy

New study into the health-related quality of life for human immunodeficiency virus (HIV) patients

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News